Author: Visionary Holdings Inc.

Posted Date:

May 4, 2026

Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees

Visionary Holdings Inc.

May 4, 2026
Visionary Holdings Inc. Announces Receipt of Nasdaq Continued Listing Deficiency Letter

Visionary Holdings Inc.

April 7, 2026
Visionary Holdings Signs Cooperation Agreement with Strategic Investment Partner for Proposed US$20 Million Investment in Qingdao Anti-Aging Project

Visionary Holdings Inc.

March 31, 2026
Visionary Holdings Inc. (NASDAQ: GV) Enters into Strategic Cooperation Agreement to Expand Distribution Capabilities for Its V-Series Anti-Aging Products in China

Visionary Holdings Inc.

March 26, 2026
UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

Visionary Holdings Inc.

March 9, 2026
Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales

Visionary Holdings Inc.

March 5, 2026
Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales

Visionary Holdings Inc.

March 5, 2026
Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

Visionary Holdings Inc.

March 2, 2026
Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract

Visionary Holdings Inc.

February 24, 2026
Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidiaries in Qingdao, Wuxi and Wuhu, Advancing Commercial Expansion in China

Visionary Holdings Inc.

February 18, 2026